56 related articles for article (PubMed ID: 20822376)
1. Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2.
Iwasaki Y; Tanaka H; Ikeada H; Okamoto R; Araki Y; Yabushita K; Kobashi H; Kariyama K; Kawaguchi M; Takaguchi K; Sakata T; Ando M; Sakaguchi K; Aoki N; Shiratori Y
Scand J Gastroenterol; 2011 Jan; 46(1):79-90. PubMed ID: 20822376
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of interferon therapy in elderly patients with chronic hepatitis C.
Koyama R; Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
Intervirology; 2006; 49(3):121-6. PubMed ID: 16428887
[TBL] [Abstract][Full Text] [Related]
3. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
[TBL] [Abstract][Full Text] [Related]
4. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
Cornberg M; Hadem J; Herrmann E; Schuppert F; Schmidt HH; Reiser M; Marschal O; Steffen M; Manns MP; Wedemeyer H
J Hepatol; 2006 Feb; 44(2):291-301. PubMed ID: 16360972
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
6. Productivity improvements in hepatitis C treatment: impact on efficacy, cost, cost-effectiveness and quality of life.
Lidgren M; Hollander A; Weiland O; Jönsson B
Scand J Gastroenterol; 2007 Jul; 42(7):867-77. PubMed ID: 17558912
[TBL] [Abstract][Full Text] [Related]
7. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
8. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.
Soriano V; Núñez M; Sánchez-Conde M; Barreiro P; García-Samaniego J; Martín-Carbonero L; Romero M; González-Lahoz J
Antivir Ther; 2005; 10(1):167-70. PubMed ID: 15751774
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C.
Cammà C; Petta S; Enea M; Bruno R; Bronte F; Capursi V; Cicchetti A; Colombo GL; Di Marco V; Gasbarrini A; Craxì A;
Hepatology; 2012 Sep; 56(3):850-60. PubMed ID: 22454336
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of treatment for chronic hepatitis C.
Koff RS
J Hepatol; 1999; 31 Suppl 1():255-8. PubMed ID: 10622598
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness analysis of different strategies of management of chronic hepatitis C infection in children.
Sinha M; Das A
Pediatr Infect Dis J; 2000 Jan; 19(1):23-30. PubMed ID: 10643846
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of combined interferon and ribavirin versus interferon alone.
Koff RS
Clin Liver Dis; 1999 Nov; 3(4):827-41. PubMed ID: 11291253
[TBL] [Abstract][Full Text] [Related]
13. Motion - the available treatments for hepatitis C are cost effective: arguments for the motion.
Terrault N
Can J Gastroenterol; 2002 Oct; 16(10):705-9. PubMed ID: 12420032
[TBL] [Abstract][Full Text] [Related]
14. Induction therapy with twice-daily interferon-beta does not improve the therapeutic efficacy of consensus interferon monotherapy for chronic hepatitis C.
Saito H; Tada S; Ebinuma H; Ishii H; Kashiwazaki K; Nishida J; Yoshida T; Zeki S; Yoshida H; Yoshioka M; Inagaki Y; Kumagai N; Hibi T
Keio J Med; 2006 Sep; 55(3):111-7. PubMed ID: 17008803
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of interferon treatment for hepatitis C.
van Leeuwen DJ
JAMA; 1999 Jun; 281(22):2083-4. PubMed ID: 10367810
[No Abstract] [Full Text] [Related]
16. Cost-effectiveness of interferon treatment for hepatitis C.
Henley E
JAMA; 1999 Jun; 281(22):2083; author reply 2084. PubMed ID: 10367809
[No Abstract] [Full Text] [Related]
17. [Isolated chronic cough during interferon therapy].
Pileire G; Leclerc P; Hermant P; Meeus E; Camus P
Presse Med; 1999 May 1-8; 28(17):913. PubMed ID: 10360188
[No Abstract] [Full Text] [Related]
18. Treatment of hepatitis C infection.
Robinson JL
Pediatr Infect Dis J; 2000 Nov; 19(11):1114. PubMed ID: 11099105
[No Abstract] [Full Text] [Related]
19. Changes in melatonin concentrations during IFN therapy.
Uchimura Y; Uchimura N; Kumashiro R; Hattori A; Sata M
J Hepatol; 1999 Dec; 31(6):1131. PubMed ID: 10604589
[No Abstract] [Full Text] [Related]
20. Interferons: effectiveness, toxicities, and costs.
Borden EC; Parkinson D
Ann Intern Med; 1996 Oct; 125(7):614-6. PubMed ID: 8815761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
